Schrier RW,Niederberger M,Weigert A,Ginés P .1994 .© 1994 by Thieme Medical Publishers. Seminars in liver disease;, : .
Cheemerla S,Balakrishnan M. .2021 .Global epidemiology of chronic liver Disease. Clin Liv Dis, 17 : 365-7.
Raja AM,Ciociola E,Ahmad IN,Dar FS,Naqvi SM,Moaeen- SM,-Din M .2020 .Genetic susceptibility to chronic liver disease in individuals from Pakistan. Int J Mol Sci, 21 : 3558-62.
Moore CM .2013 .Cirrhotic ascites review: Pathophysiology, diagnosis and management. World J Hepatol, 5 : 251-4.
Al-Busafi SA,McNabb-Baltar J,Farag A,Hilzenrat N. .2012 .Clinical manifestations of portal hypertension. Int J hepatol, : .
Iwakiri Y,Groszmann RJ .2006 .The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule. Hepatology, 43 : S121-S31.
Blenkinsopp A,Paxton P,Blenkinsopp J .2007 .. , : .
Lee RK .2012 .Intra-abdominal hypertension and abdominal compartment syndrome a comprehensive overview. Crit Care Nurse, 32 : 19-31.
Ahmad I,Niaz Z,Mumtaz SU,Komal T,Waheed I,Abaidullah S. . .Comparison of Carvedilol and Propranolol in the Treatment of Portal Hypertension in Cirrhosis. Ann King Edw Med Univ2018;, 24 : 1-5.
Samada M,Hernández JC .2012 .Prognostic factors for survival in patients with liver cirrhosis. Med Surg Res Cent, 6 : 125-44.
D'Amico G,Garcia-Tsao G,Pagliaro L .2006 .Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol, 44 : 217-31.
Schechter RB,Lemme EMO,Coelho HSM .2007 .Gastroesophageal reflux in cirrhotic patients with esophageal varices without endoscopic treatment. Arquivos de Gastroenterologia, 44 : 145-50.
Adebayo D,Neong SF,Wong F .2019 .Refractory Ascites in Liver Cirrhosis. Am J Gastroenterol, 114 : 40-7.
Khokhar N. .2002 .Spectrum of chronic liver disease in a tertiary care hospital. J Pak Med Assoc, 52 : 56-8.
Groszmann RJ,Garcia-Tsao G,Bosch J,Grace ND,Burroughs AK,Planas R .2005 .Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. New Engl J Med, 353 : 2254-61.
Biecker E. .2013 .Gastrointestinal bleeding in cirrhotic patients with portal hypertension. ISRN Hepatology, : .
D'amico G,Pasta L,Morabito A,D'Amico M,Caltagirone M,Malizia G .2014 .Competing risks and prognostic stages of cirrhosis: a 25‐year inception cohort study of 494 patients. Aliment Pharmacol Ther, 39 : 1180-93.
Gomez EV,Rodriguez YS,Bertot LC,Gonzalez AT,Perez YM,Soler EA .2013 .The natural history of compensated HCV-related cirrhosis: a prospective longterm study. J Hepatol, 58 : 434-44.
Reiberger T,Püspök A,Schoder M,Bucsics F,Datz T,C T .2017 .Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III). Wiener klinische Wochenschrift, 129 : 135-58.
Garcia-Tsao G,Groszmann RJ,Fisher RL,Conn HO,Atterbury CE,Glickman M. .1985 .Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepatology, 5 : 419-24.